化合物GLN-1062 T16037
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 224169-27-1 | ¥7,750.00 | 询底价 |
500 mg | 224169-27-1 | ¥15,500.00 | 询底价 |
5 mg | 224169-27-1 | ¥1,570.00 | 询底价 |
1 mg | 224169-27-1 | ¥638.00 | 询底价 |
1 mL | 224169-27-1 | ¥1,670.00 | 询底价 |
50 mg | 224169-27-1 | ¥5,720.00 | 询底价 |
10 mg | 224169-27-1 | ¥2,420.00 | 询底价 |
25 mg | 224169-27-1 | ¥3,930.00 | 询底价 |
Product Introduction
Bioactivity
英文名: GLN-1062
描述: GLN-1062 是 galantamine 的前体药物,在阿尔兹海默症中有研究价值。
体内活性: GLN-1062 has more than 15-fold higher bioavailability in the brain than the same doses of galantamine. In animal models of drug-induced amnesia, GLN-1062 produced several fold larger cognitive improvement than the same doses of galantamine, without exhibiting any significant levels of gastrointestinal side effects that are typical for the unmodified drug and other inhibitors of cholinesterases, such as donepezil and rivastigmin. In the ferret, dramatically reduced emetic and behavioral responses were observed when GLN-1062 was administered instead of galantamine[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 45 mg/mL (114.95 mM)
关键字: GLN 1062 | Inhibitor | inhibit | GLN-1062 | GLN1062
相关库: ReFRAME Related Library | Bioactive Compounds Library Max | Bioactive Compound Library
化合物GLN-1062 T16037信息由TargetMol中国为您提供,如您想了解更多关于化合物GLN-1062 T16037报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途